A Positive Psychology Intervention for People With New Diagnoses of Multiple Sclerosis: A Randomized Clinical Trial
In a study involving 30 individuals newly diagnosed with MS, participants were randomly assigned to either a Positive Psychology (PP) intervention or a waitlist control for 5 weeks. Statistically significant increases in positive affect and optimism were observed in those receiving the PP intervention compared to the control group.
- Tags
- #MSResearch
- Most relevant to
- —
- Human efficacy
- Demonstrated in people
- Mechanism
- Not reported
- Evidence strength
- Moderate
- Outcome
- Positive
Why it matters
This research suggests that a self-directed PP intervention may improve emotional outcomes for individuals facing new MS diagnoses, which is crucial for their adjustment to the disease.
What this does not prove
Findings are preliminary and do not prove long-term benefits. Larger trials with extended follow-up are necessary to fully assess the impact of PP on adjustment and health outcomes in MS patients.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Interventional
- Participants / samples
- 30 · Enrollment of participants in the study
- Randomised
- Yes
- Controlled
- Yes
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-05-04
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
- Biological target
- Not reported
- Pathway
- Not reported
- Population
- Individuals with new diagnoses of MS
- Size of effect
- Not reported
- Secondary endpoints
- Not reported
- MRI endpoints
- Not reported
- Biomarkers
- Not reported
- Safety
- Not reported
Original sources
- Primary evidenceA Positive Psychology Intervention for People With New Diagnoses of Multiple Sclerosis: A Randomized Clinical Trial. ↗DOI: 10.7224/1537-2073.2025-051
Supporting passages (17)
study designMETHODS: Participants were randomly asigned 1:1 to a 5-week, at-home, self-directed PP intervention or a waitlist control condition.
subjectsBACKGROUND: The period surrounding the diagnosis of multiple sclerosis (MS) is physically and emotionally challenging.
sample sizeRESULTS: Thirty participants were enrolled in the study, and 70% met the a priori threshold for feasibility.
sample size basisRESULTS: Thirty participants were enrolled in the study, and 70% met the a priori threshold for feasibility.
randomizedMETHODS: Participants were randomly asigned 1:1 to a 5-week, at-home, self-directed PP intervention or a waitlist control condition.
controlledMETHODS: Participants were randomly asigned 1:1 to a 5-week, at-home, self-directed PP intervention or a waitlist control condition.
publication date2026-05-04
interventionCONCLUSIONS: A 5-week at-home self-directed PP intervention was feasible and acceptable to individuals with new diagnoses of MS.
comparatorMETHODS: Participants were randomly asigned 1:1 to a 5-week, at-home, self-directed PP intervention or a waitlist control condition.
primary endpointThe effects of the PP intervention on a battery of patient-reported outcome measures were also examined using linear mixed-effects models.
follow upThere were statistically significant increases in positive affect (6.68; 95% CI, 2.58-10.78; P = .003) and optimism (3.03; 95% CI, 0.75-5.31; P = .01) in the intervention group compared with the waitlist control group at 5 weeks.
findingsThere were statistically significant increases in positive affect (6.68; 95% CI, 2.58-10.78; P = .003) and optimism (3.03; 95% CI, 0.75-5.31; P = .01) in the intervention group compared with the waitlist control group at 5 weeks.
limitationsLarger trials with longer follow-up are needed to fully understand the benefits of PP training to improve adjustment to MS diagnosis, which may lead to better psychosocial and health outcomes.
populationTitle: A Positive Psychology Intervention for People With New Diagnoses of Multiple Sclerosis: A Randomized Clinical Trial.
outcomeA 5-week at-home self-directed PP intervention was feasible and acceptable to individuals with new diagnoses of MS.
human efficacyThere were statistically significant increases in positive affect (6.68; 95% CI, 2.58-10.78; P = .003) and optimism (3.03; 95% CI, 0.75-5.31; P = .01) in the intervention group compared with the waitlist control group at 5 weeks.
peer reviewedPublication types: Journal Article
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.